
    
      Patients are randomized to receive oral hydration versus intravenous hydration therapy during
      concomitant intermittent intravenous Foscavir therapy for treatment of cytomegalovirus (CMV)
      retinitis. Treatment continues during 2 or 3 weeks of induction Foscavir therapy.
    
  